Response and Resistance to RAS Inhibition in Cancer is a research paper published in Cancer Discovery (2025). On theSindex it has a DataRank of 1.0. It has been cited 44 times, with 42 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.571
From this paper's citation signal
Citation Network Contribution
0.433
From 16 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 42 citers.
National Cancer Institute
Grant: P50CA127003
National Cancer Institute
Grant: U01 CA274276
National Cancer Institute
Grant: R01 CA276268
Break Through Cancer
Lustgarten Foundation (Lustgarten)
Break Through Cancer (BTC)
Lustgarten Foundation
Break Through Cancer (BTC)
Lustgarten Foundation (Lustgarten)
FWCI
17.87
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals